Market News
Massimo Group (NASDAQ: MAMO) Appoints Quenton Petersen as CEO, Transitions David Shan to Executive Chairman
Investor Brand Network - Tue Apr 21, 10:34AM CDT
Investor Brand Network - PRTGAM
Tue Apr 21, 10:34AM CDT
Massimo Group (NASDAQ: MAMO) announced the appointment of Quenton Petersen as Chief Executive Officer, effective April 14, 2026, with David Shan transitioning to Executive Chairman while remaining actively involved in the Company’s strategic...
Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach
Investor Brand Network - Tue Apr 21, 10:32AM CDT
Investor Brand Network - PRTGAM
Tue Apr 21, 10:32AM CDT
By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader
NRx Pharmaceuticals (NASDAQ: NRXP) Supports Executive Order To Accelerate Psychedelic Drug Development
Investor Brand Network - Mon Apr 20, 12:37PM CDT
Investor Brand Network - PRTGAM
Mon Apr 20, 12:37PM CDT
NRx Pharmaceuticals (NASDAQ: NRXP) welcomed a newly signed Executive Order aimed at accelerating medical treatments for serious mental illness, including expanded access to psychedelic therapies and faster regulatory pathways. The order directs...
Safe Pro Group (NASDAQ: SPAI) Repurchases 400,000 Shares Under $3M Buyback Program
Investor Brand Network - Mon Apr 20, 12:37PM CDT
Investor Brand Network - PRTGAM
Mon Apr 20, 12:37PM CDT
Safe Pro Group (NASDAQ: SPAI) reported continued execution of its share repurchase program, with 400,000 shares repurchased as of April 17, 2026, representing approximately 3.5% of its public float under a $3.0 million authorization approved in...
Rail Vision (NASDAQ: RVSN) Deploys AI, Thermal Imaging to Redefine Rail Safety
Investor Brand Network - Mon Apr 20, 12:36PM CDT
Investor Brand Network - PRTGAM
Mon Apr 20, 12:36PM CDT
Amid increased demand for advanced collision-avoidance systems as rail networks grow more complex, Rail Vision’s (NASDAQ: RVSN) artificial-intelligence (“AI”)-powered electro-optical sensors are emerging as a direct technological response. “Rail...
Beeline Holdings (NASDAQ: BLNE) Expands Embedded Mortgage Strategy Through SRG Partnership
Investor Brand Network - Mon Apr 20, 12:33PM CDT
Investor Brand Network - PRTGAM
Mon Apr 20, 12:33PM CDT
Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, is advancing its strategy to embed mortgage and title services directly into digital real estate platforms, with a newly...
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape
Investor Brand Network - Mon Apr 20, 12:31PM CDT
Investor Brand Network - PRTGAM
Mon Apr 20, 12:31PM CDT
Boca Raton, Florida-based LIXTE Biotechnology Holdings (NASDAQ: LIXT) spent 2025 expanding its presence across multiple segments of oncology innovation. “The company is best known for its clinical-stage pharmaceutical pipeline built around LB-100,...
Why Cardio Diagnostics Holdings (NASDAQ: CDIO) Is ‘One to Watch’
Investor Brand Network - Mon Apr 20, 12:28PM CDT
Investor Brand Network - PRTGAM
Mon Apr 20, 12:28PM CDT
Artificial intelligence-powered cardiovascular medicine company Cardio Diagnostics Holdings (NASDAQ: CDIO) was featured in a recent article that discussed its focus on cardiovascular disease prevention, detection, and management. The publication...
Soligenix (NASDAQ: SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status
Investor Brand Network - Mon Apr 20, 12:26PM CDT
Investor Brand Network - PRTGAM
Mon Apr 20, 12:26PM CDT
Recognition from global regulatory authorities can serve as a powerful validation of a therapy’s potential, particularly in the rare disease space where development challenges are significant and patient needs are urgent. Soligenix (NASDAQ: SNGX)...
Precision Oncology Is Shifting Toward Combination Strategies, Ultimately Changing How New Therapies Are Built
Investor Brand Network - Fri Apr 17, 10:44AM CDT
Investor Brand Network - PRTGAM
Fri Apr 17, 10:44AM CDT
Cancer treatment is entering a phase where the question is no longer which single therapy works best, but how treatments can be combined to improve outcomes. Across oncology, resistance and relapse remain persistent challenges, and the industry’s...